Are CSL Limited shares a buy after yesterday's profit result?

Does the CSL Limited (ASX:CSL) share price still have significant long-term upside potential? I think it does…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Although the CSL Limited (ASX: CSL) share price sank lower yesterday after the release of its full-year result, its shares have bounced back nicely today.

In afternoon trade the biotherapeutics company's shares are up 2% to $127.65.

Why did its shares fall yesterday?

Despite the fact CSL posted a 24% increase in underlying net profit on a constant currency basis to US$1,337 million, investors appeared to be disappointed with its FY 2018 guidance.

According to yesterday's release, management expects net profit after tax in FY 2018 to be in the range of US$1,480 million to US$1,550 million in constant currency.

This will be an increase of between 10.7% and 15.9% on this year's profit result.

Whilst this is a slower rate than this year, it is worth noting that CSL gained from one-offs in the first-half which inflated its full-year profit growth.

Should you invest?

Based on yesterday's result, CSL's shares are changing hands at approximately 34x full-year earnings.

Whilst this isn't cheap, I believe its high quality business and strong long-term profit growth potential justifies the premium.

Especially with demand for its immunoglobulin and specialty products growing strongly. Furthermore, the company recently had its Haegarda product approved. I expect this to make a significant contribution to earnings in FY 2018.

All in all, I saw enough in yesterday's result to convince me that there's still a lot of long-term upside potential in CSL's shares.

Because of this, I would put it up there with Ramsay Health Care Limited (ASX: RHC) and Nanosonics Ltd. (ASX: NAN) as one of the best buy and hold options in the healthcare sector.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »